Jiangxi Synergy Pharmaceutical Co Ltd (300636) - Total Liabilities
Based on the latest financial reports, Jiangxi Synergy Pharmaceutical Co Ltd (300636) has total liabilities worth CN¥927.61 Million CNY (≈ $135.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jiangxi Synergy Pharmaceutical Co Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Jiangxi Synergy Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Jiangxi Synergy Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Jiangxi Synergy Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jiangxi Synergy Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Fjr Optoelectronic Technology Co Ltd
SHG:688272
|
China | CN¥304.51 Million |
|
Suzhou Kelida Bldg &
SHG:603828
|
China | CN¥3.37 Billion |
|
Doright Co.Ltd.
SHE:300950
|
China | CN¥425.70 Million |
|
Greene County Bancorp Inc
NASDAQ:GCBC
|
USA | $2.91 Billion |
|
First Bank
NASDAQ:FRBA
|
USA | $3.52 Billion |
|
Shenzhen Prolto Supply Chain Management Co Ltd
SHE:002769
|
China | CN¥1.40 Billion |
|
Palm Landscape Architecture Co Ltd
SHE:002431
|
China | CN¥17.12 Billion |
|
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
|
USA | $11.31 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Jiangxi Synergy Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300636 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangxi Synergy Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangxi Synergy Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual total liabilities of Jiangxi Synergy Pharmaceutical Co Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥955.80 Million ≈ $139.86 Million |
-5.44% |
| 2024-12-31 | CN¥1.01 Billion ≈ $147.91 Million |
+1.59% |
| 2023-12-31 | CN¥994.99 Million ≈ $145.60 Million |
+5.94% |
| 2022-12-31 | CN¥939.19 Million ≈ $137.43 Million |
-7.80% |
| 2021-12-31 | CN¥1.02 Billion ≈ $149.06 Million |
+56.43% |
| 2020-12-31 | CN¥651.17 Million ≈ $95.29 Million |
+110.46% |
| 2019-12-31 | CN¥309.40 Million ≈ $45.28 Million |
+112.71% |
| 2018-12-31 | CN¥145.46 Million ≈ $21.29 Million |
+70.77% |
| 2017-12-31 | CN¥85.18 Million ≈ $12.46 Million |
-25.48% |
| 2016-12-31 | CN¥114.31 Million ≈ $16.73 Million |
+12.08% |
| 2015-12-31 | CN¥101.99 Million ≈ $14.92 Million |
-26.77% |
| 2014-12-31 | CN¥139.28 Million ≈ $20.38 Million |
-11.07% |
| 2013-12-31 | CN¥156.62 Million ≈ $22.92 Million |
+9.28% |
| 2012-12-31 | CN¥143.31 Million ≈ $20.97 Million |
-- |
About Jiangxi Synergy Pharmaceutical Co Ltd
Jiangxi Synergy Pharmaceutical Co., Ltd. engages in research and development, production, and sales of chemical raw materials and pharmaceutical intermediates in China and internationally. The company offers nervous system drugs, digestive system medications, antipyretic analgesics and non-steroidal anti-inflammatory analgesics, antihypertensive drugs, anticoagulants, hypoglycemic drugs, antidepr… Read more